Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Oncol. 2001 Nov;19(5):891-5.

MSH2 and MLH1 immunodetection and the prognosis of colon cancer.

Author information

  • 1Departement d'Oncologie Moleculaire, Institut Paoli-Calmettes (IPC), Universite de la Mediterranee, Marseille Cedex 9, France.

Abstract

MSH2 and MLH1 are proteins involved in DNA reparation. They are mutated in some forms of colon cancer, i.e. hereditary non-polyposis carcinomas and a subset of sporadic carcinomas. We have studied the expression of MSH2 and MLH1 in a retrospective series of 225 colorectal carcinomas by immunohistochemistry. The results were compared to molecular tests of microsatellite instability using amplification by PCR of BAT-25 and BAT-26 repeated sequences and to histoclinical data. Positivity of both proteins was never associated with MSI phenotype. MSH2 and/or MLH1 negative tumors were frequently tumors of the proximal colon; in this subpopulation or proximal tumors, MSH2 and/or MLH1 negativity was associated with a longer disease-free survival.

PMID:
11604984
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Spandidos Publications
    Loading ...
    Support Center